文献速递技术与安全腹部CTPET

CT衍生的区域肌肉体积评估:验证其作为癌症患者全身肌肉体积预测指标的价值

Computed tomography-derived assessments of regional muscle volume: Validating their use as predictors of whole body muscle volume in cancer patients.
PubMed 文献 · Br J Radiol · 2018-10-03

研究纳入148例晚期黑色素瘤患者,以全身PET/CT测量的全身骨骼肌体积为参考标准,在发现队列(n=98)用线性回归建立区域肌肉体积预测模型,并在验证队列(n=50)评估预测效能;骨盆、腹部、胸部区域测量的R²分别为0.89、0.86、0.78,区域肌肉体积是全身肌肉体积的强预测因子。

要点

  • 骨盆区域肌肉体积与全身肌肉体积关联最强(β=1.153)。
  • 验证队列中骨盆、腹部、胸部区域模型的R²分别为0.89、0.86、0.78。
  • 区域肌肉体积可预测晚期黑色素瘤患者的全身肌肉体积。

核心结论

  • 区域骨骼肌体积测量是晚期黑色素瘤患者全身骨骼肌体积的强预测因子。
  • 首次以全身影像为参考标准验证区域骨骼肌体积在癌症患者中的使用,包括传统评估区域以外的区域。

研究设计与样本

  • 研究纳入148例接受全身正电子发射断层扫描/CT的晚期黑色素瘤患者。
  • 以CT测量的全身骨骼肌体积为参考标准,在胸部、腹部、骨盆和下肢获取CT衍生的区域骨骼肌体积测量。
  • 在发现队列(n=98)中使用线性回归将全身骨骼肌体积建模为各区域测量和临床因素的函数,并在验证队列(n=50)中通过估计各模型解释变异(R²)评估预测性能。

诊断标准与关键数值

  • 发现队列中所有区域骨骼肌体积测量均与全身骨骼肌体积显著相关(β1范围0.673-1.153,均p<0.001)。
  • 骨盆区域测量关联幅度最大(β=1.153,95%CI 0.989-1.317)。
  • 验证队列预测全身骨骼肌体积时,骨盆、腹部和胸部区域测量的R²分别为0.89、0.86、0.78。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE:: Evaluate the accuracy of CT-derived regional skeletal muscle volume (SMV) measurements to predict whole body SMV in patients with melanoma.

METHODS:: 148 patients with advanced melanoma who underwent whole body positron emission tomography/CT were studied. Whole body SMV was measured on CT and used as the reference standard. CT-derived regional measures of SMV were obtained in the thorax, abdomen, pelvis, and lower limbs. Models were developed on a discovery cohort (n-98), using linear regression to model whole body SMV as a function of each regional measure, and clinical factors. Predictive performance of the derived models was evaluated in a validation cohort (n = 50) by estimating the explained variation (R2) of each model.

RESULTS:: In the discovery cohort, all regional SMV measurements were significantly associated with whole body SMV [β1 range: 0.673-1.153, all p < 0.001)]. The magnitude of association was greatest for pelvic regional measurements {β = 1.153, [95% confidence interval (0.989, 1.317)]}. Prediction algorithms incorporating clinical variables and regional SMVs were developed to estimate whole body SMV from regional assessments. Using the validation cohort to predict whole body SMV, the R2 values for the pelvic, abdominal and thoracic regional measurements were 0.89, 0.86, 0.78.

CONCLUSION:: Regional measures of SMV are strong predictors of whole body SMV in patients with advanced melanoma.

ADVANCES IN KNOWLEDGE:: The first study utilizing whole body imaging as a reference standard validating the use of regional SMVs in cancer patients, including validating the use of regional SMVs outside of traditionally assessed areas.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Halpenny DF, Goncalves M, Schwitzer E, et al. Computed tomography-derived assessments of regional muscle volume: Validating their use as predictors of whole body muscle volume in cancer patients. Br J Radiol. 2018. PMID: 30179038. doi:10.1259/bjr.20180451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。